Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF519 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CNOT8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPT8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TMEM132A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAMP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMO7DN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101060747 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF449 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC728283 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITSN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRMT6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTBD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSM6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLCE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC17A5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLCN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on